このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Assertio Holdings マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Brendan O’Grady

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	less than a year
取締役会の平均在任期間	less than a year

経営陣の近況

Recent updates

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02

CEO（最高経営責任者

Brendan O’Grady

less than a year

在職期間

Mr. Brendan P. O'Grady serves as CEO & Director at Assertio Holdings, Inc. since May 29, 2024. Mr. O’Grady is a senior healthcare executive with more than 30 years of experience accelerating sales growth a...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Ajay Patel	Senior VP & CFO	less than a year	US$1.06m	0.16% $ 191.5k
Paul Schwichtenberg	Senior Vice President & Chief Commercial Officer	less than a year	US$1.09m	0.13% $ 155.1k
Brendan O’Grady	CEO & Director	less than a year	データなし	データなし
Bill Iskos	Senior Vice President of Operations	2.9yrs	データなし	データなし
Molly Dir	Senior Vice President of HR & Administration ?	less than a year	データなし	データなし
Sam Schlessinger	Senior VP & General Counsel	3.4yrs	データなし	0.13% $ 151.3k
Howard Franklin	Senior Vice President of Medical	1.3yrs	データなし	データなし

0.7yrs

平均在職期間

42yo

平均年齢

経験豊富な経営陣: ASRTの経営陣は経験豊富とはみなされません ( 0.6年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Brendan O’Grady	CEO & Director	less than a year	データなし	データなし
Peter Staple	Independent Chairman	20.7yrs	US$377.45k	0.33% $ 386.5k
William McKee	Independent Director	7.3yrs	US$356.52k	0.013% $ 15.3k
Heather Mason	Independent Director	5.4yrs	US$353.02k	0.22% $ 263.7k
Sigurd Kirk	Independent Director	less than a year	データなし	データなし
Jeffrey Vacirca	Independent Director	less than a year	US$245.84k	0.066% $ 77.7k
Sravan Emany	Independent Director	less than a year	US$223.80k	データなし

1.0yrs

平均在職期間

59.5yo

平均年齢

経験豊富なボード: ASRTの取締役会は経験豊富ではない ( 0.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Assertio Holdings マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

Assertio Holdings, Inc. Announces CFO Changes

Recent updates

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

The Buxton Helmsley Group Sends Letter to Assertio Holdings

The Buxton Helmsley Group Sends Letter to Assertio Holdings

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Assertio Holdings, Inc. to Report Q1, 2024 Results on May 06, 2024

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 27%

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Full year 2023 earnings: EPS misses analyst expectations

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Assertio Holdings, Inc. to Report Q4, 2023 Results on Mar 11, 2024

New major risk - Share price stability

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Assertio Holdings, Inc

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

New minor risk - Market cap size

Assertio Holdings, Inc. Announces CFO Changes

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Assertio Holdings, Inc. to Report Q3, 2023 Results on Nov 08, 2023

President recently sold US$479k worth of stock

President notifies of intention to sell stock

New major risk - Shareholder dilution

Independent Director notifies of intention to sell stock

New minor risk - Share price stability

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $25 million.

Consensus revenue estimates increase by 13%, EPS downgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).

Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors

Assertio Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently sold US$652k worth of stock

President exercised options and sold US$2.9m worth of stock

Consensus EPS estimates fall by 30%, revenue upgraded

Assertio Holdings, Inc. Raises Earnings Guidance for the Full Year of 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 17%

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued

Price target increased by 9.6% to US$7.88

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Investor sentiment improves as stock rises 18%

Consensus EPS estimates increase by 164%

President exercised options and sold US$257k worth of stock

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Investor sentiment deteriorated over the past week

Insufficient new directors

Assertio Holdings, Inc. Revises Net Product Sales Guidance for the Year 2022

Assertio Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Assertio Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Assertio Holdings Looks Good To Rebound After Recent Price Plunge

Assertio Holdings: Substantial Upside

Assertio Holdings, Inc. Raises Earnings Guidance for the Year 2022

Assertio Therapeutics Q2 2022 Earnings Preview

Assertio Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Assertio Holdings: Management Still Swimming Against The Tide

Assertio's Phenomenal Turnaround

Assertio Holdings, Inc. Re-Affirms Sales Guidance for the Full Year of 2022

Levi & Korsinsky, LLP Announces Propose Settlement Against Assertio Therapeutics, Inc. Securities Litigation

Assertio Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Assertio Holdings: Recent Breakout To Lead To Sustained Gains

マネジメント基準チェック /04